Association of Surgery and Chemotherapy in Metastatic Testicular Cancer

  • G Pizzocaro
  • S Monfardini
Part of the Ettore Majorana International Science Series book series (EMISS, volume 1)


Remarkable progress has recently been achieved in the multidrug therapy of non seminomatous testicular cancer (1,2,5,9) and the association of surgery and chemotherapy has proved useful in improving the prognosis of patients with widespread disease (4,6,11). On the other hand, the role of adjunctive chemotherapy has not yet been clearly defined although it has been suggested it should be able to destroy residual micrometastases (10).


Testicular Cancer Embryonal Carcinoma Mature Teratoma Spermatic Vessel Pure Seminoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cheng, E., Cvitkovic, E., Wittes R. E. and Golbey, R. B., Germ cell tumours. VAB II in metastatic testicular cancer. Cancer, 42, 2162–2168 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    Einhorn, L. H. and Donohue, J. P., Cis-diamminedichloroplatinum Vinblastine and Bleomycin combination chemotherapy in disseminated testicular cancer. Ann. Int. Med., 87, 293–298 (1977).PubMedCrossRefGoogle Scholar
  3. 3.
    Hoeffken, K. and Schmidt, C. G., Chemotherapy for localised testicular teratomas. Brit. J. Cancer, 37, 479–480 (1978).Google Scholar
  4. 4.
    Johnson, D. E., Bracken, R. B., Ayala, A. G. and Samuels, M. L. Retroperitoneal lymphadenectomy as adjunctive therapy in selected cases of advanced testicular carcinoma. J. Urol., 116 66–68 (1976).PubMedGoogle Scholar
  5. 5.
    Klepp, O., Klepp, R., Høst, H., Asbjørnsengg, Talle, K. and Stenwig, A. E., Combination chemotherapy of germ cell tumours of the testis with Vincristine, Adriamycin, Cyclophosphamide, Actinomycin D and Medroxyprogesterone Acetate. Cancer, 40, 638–646 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    Merrin, C., Takita, H., Beckley, S. and Kassis, J., Treatment of recurrent and widespread testicular tumour by radical reductive surgery and multiple sequential chemotherapy. J. Urol. 117, 291–295 (1977).PubMedGoogle Scholar
  7. 7.
    Merrin, C. E. and Takita, H., Cancer reductive surgery. Report of the simultaneous excision of abdominal and thoracic metastases from widespread testicular tumours. Cancer, 42, 495–501 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    Norton, L. and Simon, R., Tumour size, sensitivity to therapy and design of treatment schedules. Cancer Treat. Rep. 61, 1307–1317 (1977).PubMedGoogle Scholar
  9. 9.
    Samuels, M. L., Johnson, D. E. and Holoye, P. Y., Continuous intravenous Bleomycin therapy with Vinblastine in stage III testicular neoplasia. Cancer Chemo. Rep., 59, 563–570 (1975).Google Scholar
  10. 10.
    Shabel, F. M. Jr., Concepts for systemic treatment of micro- metastases. Cancer, 35, 15–24 (1975).CrossRefGoogle Scholar
  11. 11.
    Skinner, D. G., Non seminomatous testis tumours: a plan of management based on 96 patients to improve survival in all stages by combined therapeutic modalities. J. Urol., 115, 65–69 (1976).PubMedGoogle Scholar
  12. 12.
    Staubitz, W. J., Early, K. S., Magoss, I. V. and Murphy, G. P., Surgical management of testis tumour. J. Urol., 65, 113–117 (1973).Google Scholar
  13. 13.
    Tyrrell, C. J. and Peckham, M. J., The response of lymphnode metastases of testicular teratoma to radiation therapy. Brit. J. Urol., 48, 363–370 (1976).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • G Pizzocaro
    • 1
  • S Monfardini
    • 1
  1. 1.Departments of Surgical Oncology and Medical OncologyNational Tumour InstituteMilanItaly

Personalised recommendations